Practical aspects of the ligand-binding and enzymatic properties of human serum albumin

…, VTG Chuang, M Otagiri - Biological and …, 2002 - jstage.jst.go.jp
Recent work with approaches like recombinant mutants and X-ray crystallography has
given much new information about the ligand-binding properties of human serum albumin (HSA). …

Cyclodextrins in drug carrier systems.

K Uekama, M Otagiri - Critical reviews in therapeutic drug carrier …, 1987 - europepmc.org
One of the important characteristics of cyclodextrins is the formation of an inclusion complex
with a variety of drug molecules in solution and in the solid state. As a consequence of …

Albumin–drug interaction and its clinical implication

…, VTG Chuang, T Maruyama, M Otagiri - Biochimica et Biophysica …, 2013 - Elsevier
Background Human serum albumin acts as a reservoir and transport protein for endogenous
(eg fatty acids or bilirubin) and exogenous compounds (eg drugs or nutrients) in the blood. …

Structural basis of the drug-binding specificity of human serum albumin

…, I Petitpas, AA Bhattacharya, M Otagiri… - Journal of molecular …, 2005 - Elsevier
… in the complex with thyroxine, a significantly larger molecule (M r 777 Da) 6 (Figure 3(d)
and (e)). For CMPF and the drugs used in this study (M r ∼310 Da) the greatest movement is …

[HTML][HTML] p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase

…, M Tanaka, M Fukagawa, M Otagiri… - Kidney international, 2013 - Elsevier
The accumulation of p-cresyl sulfate (PCS), a uremic toxin, is associated with the mortality
rate of chronic kidney disease patients; however, the biological functions and the mechanism …

Pharmaceutical strategies utilizing recombinant human serum albumin

…, U Kragh-Hansen, M Otagiri - Pharmaceutical …, 2002 - Springer
Gene manipulation techniques open up the possibility of making recombinant human serum
albumin (rHSA) or mutants with desirable therapeutic properties and for protein fusion …

Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity

…, U KRAGH-HANSEN, M OTAGIRI - Biochemical …, 2000 - portlandpress.com
… 25 Maruyama, T., Lin, CC, Yamasaki, K., Miyoshi, T., Imai, T., Yamasaki, M. and Otagiri, M.
(1993) … and Otagiri, M. (1993) Study of interaction of carprofen and its enantiomers with human …

Characterization of site I on human serum albumin: concept about the structure of a drug binding site

…, T Maruyama, U Kragh-Hansen, M Otagiri - … et Biophysica Acta (BBA …, 1996 - Elsevier
… With sodium phosphate dibasic and sodium phosphate monobasic, 0.067 M phosphate …
The mobile phase for iodipamide was 0.1 M acetate buffer (pH 5.5)-acetonitrile (90:10, v/v) on a …

Species differences of serum albumins: I. Drug binding sites

T Kosa, T Maruyama, M Otagiri - Pharmaceutical research, 1997 - Springer
Purpose. The purpose of this study was the classification and identification of drug binding
sites on albumins from several species in order to understand species differences of both …

Study of interaction of carprofen and its enantiomers with human serum albumin—I: Mechanism of binding studied by dialysis and spectroscopic methods

…, T Maruyama, T Okada, K Yamasaki, M Otagiri - Biochemical …, 1993 - Elsevier
Otagiri M, Masuda K, Imai T, Imamura Y and Yamasaki M, Binding of pirprofen to human
serum albumin studied by dialysis and spectroscopy techniques. Biochem Pharmacol 38: 1-7, …